Threshold Pharmaceuticals $4.13

down -0.22


23/4/2014 08:10 PM  |  NASDAQ : THLD  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get THLD Trend Analysis - it has underperformed the S&P 500 by 34%

Partner Headlines

  1. US Stock Futures Flat After Record Close

    Benzinga
  2. Threshold Pharma Reports New Clinical Data on TH-302, Says One CR, Two ...

    Benzinga
  3. Threshold New Data on Combination of TH-302 and Avastin in Recurrent Glioblastoma ...

    Benzinga
  4. Threshold Pharma Reports TH-302 Data Will Be Presented at ASH

    Benzinga
  5. Threshold Pharma Reports Early Clinical Data for Combining TH-302, Says ...

    Benzinga
  6. Threshold Pharmaceuticals Initiates Phase 2 Study of TH-302 in Patients ...

    Benzinga
  7. UPDATE: Piper Jaffray Initiates Threshold Pharmaceuticals at Neutral Ahead ...

    Benzinga
  8. Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  9. Threshold Pharmaceuticals Announces Agreement With U.S. FDA on a Special ...

    Benzinga
  10. Maxim Group Reiterates Buy Rating, $10 PT on Threshold Pharmaceuticals

    Benzinga
  11. UPDATE: Maxim Group Initiates Threshold Pharmaceuticals at Buy on Doxorubicin ...

    Benzinga
  12. Threshold Pharmaceuticals (THLD) Loses 20.5% on Mixed Data from Drug Trial

    MarketIntelligenceCenter
  13. Morning Market Losers

    Benzinga
  14. FROM EARLIER: Threshold Pharma Says Study of TH-302 Demonstrated a Statistically ...

    Benzinga
  15. Eli Lilly &, Limited Brands Included in Stocks Up on High Volume Friday

    FoxBusiness
  16. Threshold Pharmaceuticals Appoints Laura G. Hansen, Ph.D., Senior Director, ...

    Benzinga
  17. Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  18. Benzinga's Top Initiations

    Benzinga
  19. Bullish Brokerage Note Propels Threshold Pharmaceuticals' Call Volume

    SchaeffersResearch
  20. Threshold Pharma Pops 18% on Positive Quarterly Results

    Benzinga
  21. Nine ETFs Trading Near 52-Week Highs

    Benzinga
  22. These Small-Cap Stocks Have Already More Than Doubled In 2012!

    Benzinga
  23. Threshold Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results ...

    Benzinga
  24. Benzinga's Microcap Movers for Friday February 3, 2012

    Benzinga
  25. Financial Breakfast: Morning News Summary for February 3, 2012

    Benzinga
  26. Threshold Pharmaceuticals Announces Promising Phase 1 Clinical Trial Results ...

    Benzinga
Trading Center